China Stocks Are Handily Beating U.S. Since Coronavirus Outbreak. Here’s Why

China Stocks Are Handily Beating U.S. Since Coronavirus Outbreak. Here’s Why

(Bloomberg) -- While U.S. investors are grappling with a violent sell-off as the coronavirus spreads, their Chinese counterparts at the heart of the outbreak are back to making decent money again.China’s swift and strict measures to contain the virus, optimism over fiscal and monetary stimulus, and relatively reasonable valuations are among the key reasons for the recent relative rebound, according to market participants. Perhaps more importantly, China investors have already gone through the panic stage that their U.S. counterparts are experiencing now, they said.A gauge of Chinese stocks in Shanghai and Shenzhen just posted its best week in a year -- a 5% gain -- after touching a two-year high on Thursday. Meanwhile, the S&P 500 Index has fallen more than 12% from the record it reached last month, with volatility surging.“It is interesting that China has started to outperform world equities since the start of February as confidence grows that...

Bayer Investor Sues Top Officials for ‘Disastrous’ Monsanto Deal

(Bloomberg) -- A Bayer AG investor sued the board and other top company officials, claiming the “disastrous” 2018 acquisition of Monsanto Co. eroded the company’s share value by saddling it with potentially billions of dollars in liability from Roundup lawsuits.Bayer AG’s board and other top officials were sued by an investor who claims the “disastrous” 2018 acquisition of Monsanto Co. saddled the company with potentially billions of dollars in costly lawsuits over Roundup herbicide.The German chemical giant “has been engulfed by a tsunami” of litigation alleging Monsanto’s Roundup causes cancer, eroding Bayer’s share value, Rebecca Haussmann said in a suit filed Friday in New York state court in Manhattan. She demanded compensation and punitive damages, as well as disgorgement of pay for executives who helped arrange the deal.Bayer last month estimated it faces about 48,600 U.S. plaintiffs in Roundup cases, up from 18,400 in July. While the company insists the herbicide...

Should You Follow This Top Analyst and Buy Roku Stock?

Roku (ROKU) stock fell along with the overall market when news came out that the coronavirus had spread considerably beyond China. Year-to-date, Roku is down nearly 24%, and investors are still expecting a volatile ride ahead so long as the coronavirus prevails.RBC analyst Mark Mahaney, however, believes Roku is set up for further growth in 2020, after what can only be described as a mercurial ascent in 2019, in which Roku’s share price skyrocketed by almost 350%.The 5-star analyst reiterated an Outperform rating on Roku shares, while keeping his $170 price target intact. Should the target be met, shares could be in for a 66% twelve-month gain. (To watch Mahaney’s track record, click here)Mahaney recently held a conference call with Roku CFO Steve Louden to discuss the company’s future prospects and plans. Let’s look at some of the analyst's key takeaways:The Long Term PlanRoku’s road to profitability and expansion will be...